Ottobock stock: Results due November 12, 2026. Ottobock stock sits 2.61 percent below Xetra close

Published on 10/19/2026 at 15:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2025 core revenue rose 11.70 percent to EUR 200.00 million. Ottobock stock costs EUR 52.20 on October 19, 2026, 2.61 percent below Xetra close.

Reporting date and operating progress

Ottobock's next quarterly report is scheduled for November 12, 2026.
Core revenue rose 11.70 percent to EUR 200.00 million in fiscal year 2025.
Ottobock stock costs EUR 52.20 at Lang & Schwarz on October 19, 2026 at 3:31 p.m. CEST, 2.61 percent below the Xetra close of October 16, 2026.
Adjusted core EBITDA reached EUR 52.51 million in fiscal year 2025, up 29.50 percent.

Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock's next quarterly report is scheduled for November 12, 2026, according to the company's investor-relations calendar. At Lang & Schwarz, the stock was trading at EUR 52.20 on October 19, 2026 at 3:31 p.m. CEST, down 2.61 percent versus the Xetra close of October 16, 2026 at EUR 53.60.

Revenue growth supports the next update

The company reported core revenue of EUR 200.00 million for fiscal year 2025, an increase of 11.70 percent. Adjusted core EBITDA reached EUR 52.51 million, up 29.50 percent from the prior year, while the adjusted core EBITDA margin rose to 26.30 percent from 22.70 percent. These figures give the November report a clear operating benchmark.

Ottobock's investor-relations page describes the group as a medical technology company focused on prosthetics, neuro-orthotics and exoskeletons. The company said it operated in 45 countries with almost 9,300 full-time employees and more than 430 patient-care centers, according to its investor-relations information.

Price position after the Xetra close

The October 19 quotation is EUR 1.40 below the October 16 Xetra close, equivalent to a 2.61 percent decline. The bid was EUR 52.10 and the ask EUR 52.30 at the same Lang & Schwarz timestamp, leaving a EUR 0.20 spread. The stock therefore remains below the most recent completed Xetra session's closing level.

Valuation and upcoming dates

Ottobock's next reporting date is November 12, 2026, for its third-quarter 2026 quarterly communication in Duderstadt. The investor-relations calendar also lists a BNP Paribas MidCap CEO Conference on November 16, 2026 and the Jefferies Global Healthcare Conference from November 18 to November 19, 2026.

For investors, the key comparison is now between the October price level and the operating base established in fiscal year 2025. The next report can show whether the 11.70 percent core-revenue growth and the 26.30 percent adjusted core EBITDA margin have continued into the third quarter.

Ottobock stock after the latest quote

The dated market figures place the stock below its October 16 Xetra close while the next corporate reporting date remains November 12, 2026. The operating figures from fiscal year 2025 provide the clearest benchmark for reading that update.

The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.